Herman Goossens
- Applied Microbiology and Biotechnology top 0.01%
- Antibiotic Use and Resistance 41
- Molecular Medicine top 0.05%
- Antibiotic Resistance in Bacteria 36
- Clinical Biochemistry top 0.1%
- Bacterial Identification and Susceptibility Testing 35
- Endocrinology top 0.2%
- Infectious Diseases top 0.2%
- Antimicrobial Resistance in Staphylococcus 32
- SARS-CoV-2 and COVID-19 Research 19
-
- Pneumonia and Respiratory Infections 41
- Respiratory viral infections research 25
-
- Streptococcal Infections and Treatments 19
- Co-authors
- Monique ElseviersMatus FerechRobert Vander StichelePeter VandammeMargareta IevenCarl VaelWen‐Chien KoAnne von Gottberg
- Partner nations
- BelgiumNetherlandsUnited Kingdom
In The Last Decade
Herman Goossens
266 papers receiving 13.3k citations
Hit Papers
Peers
Comparison fields: 5 of 199
- Applied Microbiology and Biotechnology 3.5k
- Molecular Medicine 3.0k
- Clinical Biochemistry 1.3k
- Endocrinology 980
- Infectious Diseases 3.2k
Countries citing papers authored by Herman Goossens
This map shows the geographic impact of Herman Goossens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Herman Goossens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Herman Goossens more than expected).
Fields of papers citing papers by Herman Goossens
This network shows the impact of papers produced by Herman Goossens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Herman Goossens. The network helps show where Herman Goossens may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Herman Goossens, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 1 | |
| 4 | 2022 | 11 | |
| 5 | 2022 | 2 | |
| 6 | 2022 | 14 | |
| 7 | 2021 | 13 | |
| 8 | 2021 | 27 | |
| 9 | 2021 | 8 | |
| 10 | 2020 | 454 | |
| 11 | 2016 | 34 | |
| 12 | 2016 | 18 | |
| 13 | 2016 | 17 | |
| 14 | 2015 | 8 | |
| 15 | 2015 | 2 | |
| 16 | 2015 | 6 | |
| 17 | 2006 | 24 | |
| 18 | 2006 | 7 | |
| 19 | ['Evidence-based' perioperative antibiotic prophylaxis policy in Belgian hospitals after a change in the reimbursement system]. | 2001 | 8 |
| 20 | 1998 | 32 |
About Herman Goossens
Herman Goossens is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Clinical Biochemistry, having authored 273 papers that have together received 13.8k indexed citations. Recurring topics across this work include Pneumonia and Respiratory Infections (41 papers), Antibiotic Use and Resistance (41 papers), Antibiotic Resistance in Bacteria (36 papers), Bacterial Identification and Susceptibility Testing (35 papers), Antimicrobial Resistance in Staphylococcus (32 papers), Respiratory viral infections research (25 papers), Streptococcal Infections and Treatments (19 papers) and SARS-CoV-2 and COVID-19 Research (19 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (3.5k citations), Molecular Medicine (3.0k citations) and Clinical Biochemistry (1.3k citations). Herman Goossens has collaborated with scholars based in Belgium, Netherlands and United Kingdom. Frequent co-authors include Monique Elseviers, Matus Ferech, Robert Vander Stichele, Peter Vandamme, Margareta Ieven, Carl Vael, Wen‐Chien Ko, Anne von Gottberg, Zwi Berneman and Kristine Desager. Their work appears in journals such as Nature, The Lancet and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.